{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+Fluticasone+furoate&page=7", "query": { "intervention": "Placebo Fluticasone furoate", "page": 7 }, "page_size": 10 }, "pagination": { "page": 7, "page_size": 10, "total_count": 170, "total_pages": 17, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+Fluticasone+furoate&page=8&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo+Fluticasone+furoate&page=6&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-14T09:33:50.679Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT02483975", "title": "Effect of Fluticasone Furoate Inhalation Powder on the Hypothalamic-pituitary-adrenocortical Axis of Children Aged 5-11 Years With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "FF", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Montelukast", "type": "DRUG" }, { "name": "Albuterol/Salbutamol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "5 Years", "maximum_age": "11 Years", "sex": "ALL", "summary": "5 Years to 11 Years" }, "enrollment_count": 111, "start_date": "2015-10-09", "completion_date": "2016-06-21", "has_results": true, "last_update_posted_date": "2020-04-27", "last_synced_at": "2026-10-14T09:33:50.679Z", "location_count": 14, "location_summary": "Little Rock, Arkansas • Alhambra, California • Costa Mesa, California + 8 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "Alhambra", "state": "California" }, { "city": "Costa Mesa", "state": "California" }, { "city": "Huntington Beach", "state": "California" }, { "city": "Newport Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02483975" }, { "nct_id": "NCT06850805", "title": "Efficacy and Safety of 186 mcg of OPN-375 Nasal Spray Twice a Day (BID) in Adolescents With Chronic Rhinosinusitis Without Nasal Polyps", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Chronic Rhinosinusitis Without Nasal Polyps" ], "interventions": [ { "name": "OPN-375", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Optinose US Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "12 Years to 17 Years" }, "enrollment_count": 84, "start_date": "2025-07-28", "completion_date": "2028-10-31", "has_results": false, "last_update_posted_date": "2026-09-18", "last_synced_at": "2026-10-14T09:33:50.679Z", "location_count": 24, "location_summary": "Huntsville, Alabama • Gilbert, Arizona • Los Angeles, California + 20 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Gilbert", "state": "Arizona" }, { "city": "Los Angeles", "state": "California" }, { "city": "Orange", "state": "California" }, { "city": "Sacramento", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06850805" }, { "nct_id": "NCT03112577", "title": "Study of REGN3500 and Dupilumab in Patients With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Asthma, Allergic" ], "interventions": [ { "name": "REGN3500", "type": "DRUG" }, { "name": "Dupilumab", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" }, { "name": "Fluticasone propionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Regeneron Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 32, "start_date": "2017-06-15", "completion_date": "2019-12-09", "has_results": false, "last_update_posted_date": "2020-01-18", "last_synced_at": "2026-10-14T09:33:50.679Z", "location_count": 1, "location_summary": "Cypress, California", "locations": [ { "city": "Cypress", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03112577" }, { "nct_id": "NCT01090024", "title": "Bi 671800 in Asthmatic Patients on Inhaled Corticosteroids", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "BI 671800", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 108, "start_date": "2010-03-01", "completion_date": "2011-02-18", "has_results": true, "last_update_posted_date": "2022-05-11", "last_synced_at": "2026-10-14T09:33:50.679Z", "location_count": 14, "location_summary": "Huntington Beach, California • Mission Viejo, California • Stockton, California + 11 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Mission Viejo", "state": "California" }, { "city": "Stockton", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Denver", "state": "Colorado" } ], "official_url": "https://clinicaltrials.gov/study/NCT01090024" }, { "nct_id": "NCT01147848", "title": "HZA113091 Efficacy and Safety of Fluticasone Furoate/Vilanterol (GW642444) in Adults and Adolescents", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Fluticasone furoate/Vilanterol Inhalation Powder", "type": "DRUG" }, { "name": "Fluticasone propionate/salmeterol Inhalation Powder", "type": "DRUG" }, { "name": "Placebo (1)", "type": "DRUG" }, { "name": "Placebo (2)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 810, "start_date": "2010-06", "completion_date": "2011-07", "has_results": true, "last_update_posted_date": "2017-01-18", "last_synced_at": "2026-10-14T09:33:50.679Z", "location_count": 25, "location_summary": "Huntington Beach, California • Los Angeles, California • Riverside, California + 21 more", "locations": [ { "city": "Huntington Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Riverside", "state": "California" }, { "city": "Rolling Hills Estates", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT01147848" }, { "nct_id": "NCT00883168", "title": "A Study to Evaluate the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Seasonal Allergic Rhinitis" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "azelastineHcl", "type": "DRUG" }, { "name": "fluticasone propionate", "type": "DRUG" }, { "name": "azelastine Hcl/fluticasone propionate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Meda Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1791, "start_date": "2009-04", "completion_date": "2009-07", "has_results": true, "last_update_posted_date": "2013-06-24", "last_synced_at": "2026-10-14T09:33:50.679Z", "location_count": 45, "location_summary": "Scottsdale, Arizona • Encinitas, California • Fountain Valley, California + 35 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Encinitas", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00883168" }, { "nct_id": "NCT03012061", "title": "Phase IIb Study of Umeclidinium (UMEC) Bromide Versus Placebo in Subjects With Asthma", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Asthma" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "UMEC", "type": "DRUG" }, { "name": "Fluticasone Furoate", "type": "DRUG" }, { "name": "Albuterol/salbutamol", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 425, "start_date": "2017-01-25", "completion_date": "2018-05-30", "has_results": true, "last_update_posted_date": "2020-10-28", "last_synced_at": "2026-10-14T09:33:50.679Z", "location_count": 19, "location_summary": "Tempe, Arizona • Rolling Hills Estates, California • Colorado Springs, Colorado + 15 more", "locations": [ { "city": "Tempe", "state": "Arizona" }, { "city": "Rolling Hills Estates", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Topeka", "state": "Kansas" }, { "city": "Natchitoches", "state": "Louisiana" } ], "official_url": "https://clinicaltrials.gov/study/NCT03012061" }, { "nct_id": "NCT02402465", "title": "Factors Involved in Dymista's Superior Clinical Efficacy in the Treatment of Seasonal Allergic Rhinitis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Allergic Rhinitis" ], "interventions": [ { "name": "Placebo", "type": "DRUG" }, { "name": "Fluticasone propionate", "type": "DRUG" }, { "name": "Fluticasone/Azelastine nasal spray", "type": "DRUG" }, { "name": "Nasal Allergen Challenge", "type": "PROCEDURE" } ], "intervention_types": [ "DRUG", "PROCEDURE" ], "sponsor": "University of Chicago", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 22, "start_date": "2015-02", "completion_date": "2020-02", "has_results": true, "last_update_posted_date": "2024-10-17", "last_synced_at": "2026-10-14T09:33:50.679Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT02402465" }, { "nct_id": "NCT00740792", "title": "A Study Evaluating the Safety and Effectiveness of a Nasal Spray to Treat Seasonal Allergies", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Seasonal Allergic Rhinitis" ], "interventions": [ { "name": "azelastine HCl/fluticasone propionate", "type": "DRUG" }, { "name": "azelastine Hcl", "type": "DRUG" }, { "name": "fluticasone propionate", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Meda Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 776, "start_date": "2008-08", "completion_date": "2008-11", "has_results": true, "last_update_posted_date": "2012-09-07", "last_synced_at": "2026-10-14T09:33:50.679Z", "location_count": 39, "location_summary": "Scottsdale, Arizona • Encinitas, California • Fountain Valley, California + 32 more", "locations": [ { "city": "Scottsdale", "state": "Arizona" }, { "city": "Encinitas", "state": "California" }, { "city": "Fountain Valley", "state": "California" }, { "city": "Fresno", "state": "California" }, { "city": "Long Beach", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00740792" }, { "nct_id": "NCT02249663", "title": "Clinical Equivalence of Azelastine Hydrochloride and Fluticasone Propionate, 137/50 mcg Nasal Spray to Dymista™", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Seasonal Allergic Rhinitis" ], "interventions": [ { "name": "Azelastine hydrochloride and Fluticasone propionate", "type": "DRUG" }, { "name": "Dymista™", "type": "DRUG" }, { "name": "Placebo", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Teva Pharmaceuticals USA", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 1535, "start_date": "2014-08", "completion_date": null, "has_results": false, "last_update_posted_date": "2014-09-25", "last_synced_at": "2026-10-14T09:33:50.679Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT02249663" } ] }